Abstract: The present disclosure relates to an all-solid-state battery having an anode layer including a solid electrolyte metal-organic framework; a solid electrolyte layer disposed on the anode layer; and a cathode layer disposed on the solid electrolyte layer. The all-solid-state battery may further include a lithium layer interposed between the anode layer and the solid electrolyte layer.

Abstract: A curable composition includes (A) a quantum dot; (B) a polymerizable compound; (C) a compound represented by Chemical Formula 1; and (D) a polymerization initiator. A resin layer manufactured utilizing the curable composition, and a display device including the resin layer are also provided. In Chemical Formula, each substituent is the same as defined in the detailed description.

Abstract: A photosensitive resin composition including (A) a quantum dot; (B) a binder resin including a structural unit represented by Chemical Formula 1; (C) a photopolymerizable monomer; (D) a photopolymerization initiator; and (E) a solvent, photosensitive resin layer manufactured using the same, and a color filter including the photosensitive resin layer. (In Chemical Formula 1, each substituent is the same as defined in the specification.

Abstract: A curable composition includes: (A) a quantum dot; (B) a binder resin including a structural unit represented by Chemical Formula 1-1, a structural unit represented by Chemical Formula 1-2, a structural unit represented by Chemical Formula 1-3, and a structural unit represented by Chemical Formula 2; and (C) a solvent. A resin layer is manufactured using the curable composition, and a display device includes the resin layer.

Abstract: A curable composition includes (A) a quantum dot; (B) a polymerizable compound; (C) a compound represented by Chemical Formula 1; and (D) a polymerization initiator. A resin layer manufactured utilizing the curable composition, and a display device including the resin layer are also provided. In Chemical Formula, each substituent is the same as defined in the detailed description.

Abstract: A curable composition includes: (A) a quantum dot; (B) a binder resin including a structural unit represented by Chemical Formula 1-1, a structural unit represented by Chemical Formula 1-2, a structural unit represented by Chemical Formula 1-3, and a structural unit represented by Chemical Formula 2; and (C) a solvent. A resin layer is manufactured using the curable composition, and a display device includes the resin layer.

Abstract: A photosensitive resin composition including (A) a quantum dot; (B) a binder resin including a structural unit represented by Chemical Formula 1; (C) a photopolymerizable monomer; (D) a photopolymerization initiator; and (E) a solvent, photosensitive resin layer manufactured using the same, and a color filter including the photosensitive resin layer. (In Chemical Formula 1, each substituent is the same as defined in the specification.

Abstract: Disclosed are a photosensitive resin composition including a composite dye that includes a red fluorescent dye re-emitting light at a 400 to 800 nm fluorescent wavelength; and a metal complex dye including at least one metal ion selected from Mg, Ni, Co, Zn, Cr, Pt, and Pd, and a color filter using the same.

Abstract: Disclosed are a photosensitive resin composition including a composite dye that includes a red fluorescent dye re-emitting light at a 400 to 800 nm fluorescent wavelength; and a metal complex dye including at least one metal ion selected from Mg, Ni, Co, Zn, Cr, Pt, and Pd, and a color filter using the same.

Abstract: A cartridge for an edible film dispenser protects a mounted edible film having a roll form, enables easy mounting of the edible film in the edible film container, and simplifies the structure of the edible film dispenser. The cartridge includes an edible film tape, which has a cylindrical main bobbin and a cylindrical take-up bobbin, a cartridge body, which includes a main shaft, a draw shaft, a take-up shaft, and an edge perpendicular wall, which are spaced apart from each other, and a plate-like cartridge cover, which has a size and profile equal to those of the cartridge body.

Abstract: A cartridge for an edible film dispenser is provided for protecting a mounted edible film having a roll form, enabling easy mounting of the edible film in the edible film dispenser, and simplifying the structure of the edible film dispenser. The cartridge comprises an edible film tape, which has a cylindrical main bobbin and a cylindrical take-up bobbin, a cartridge body, which includes a main shaft, a draw shaft, a take-up shaft, and an edge perpendicular wall, which are spaced apart from each other, and a plate-like cartridge cover, which has a size and profile equal to those of the cartridge body.

Abstract: The invention relates to novel pyridine derivatives having an inhibitory effect on production of cytokines, which are involved in inflammatory responses, thus suggesting its usefulness as therapeutic agents for treating diseases related to inflammation, immune, chronic inflammation as well as an agent having an anti-inflammatory and analgesic effect. Further, this invention relates to a method of manufacturing the same and a pharmaceutical composition containing the same.

Abstract: The present invention relates to an inclusion complex containing a benzimidazole derivative with excellent storage stability and a method of its preparation. In particular, the present invention relates to an inclusion complex containing a benzimidazole derivative with improved storage stability and a method of its preparation, where an inclusion complex is manufactured by performing an inclusion reaction by combining a benzimidazole derivative, cyclodextrin and a water-soluble polymer in an aqueous alkali solution in order to be formulated after stabilizing an acid-unstable benzimidazole derivative.

Abstract: The present invention relates to an acid salt of amlodipine gentisate and a method of its preparation. More particularly, the present invention relates to a crystalline acid salt of amlodipine gentisate of the following formula 1 prepared by reacting amlodipine and gentisic acid, which is useful for the treatment of cardiovascular diseases and has the advantages of low toxicity, excellent stability, improved pharmaceutical efficacies and long-lasting concentration in blood.